透析患者中的萨库比特里尔/瓦尔沙坦:关于当前前前景的更新
Leonardo Spatola1, Matthias Zeiler2, Antonio Granata3
1Division of Nephrology and Dialysis, Ospedale Sant' Antonio Abate, AspTrapani, via Cosenza, Erice (TP), Trapani, Italy. leonardospatola@yahoo.it.
Cardiovascular drugs and therapy
|June 22, 2023
概括
萨库比特里尔/瓦尔沙坦在心力衰竭方面表现有前途,但其在末期脏疾病 (ESRD) 患者中的使用需要更多的研究. 目前的研究是有限的,使得透析患者的益处和风险不明确.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 与ACE抑制剂相比,Sacubitril/Valsartan是一种非普利辛抑制剂和血管激素II受体阻断剂组合,改善了心力衰竭患者的治疗结果.
- 随机对照试验已经排除了末期病 (ESRD) 的患者.
研究的目的:
- 评估Sacubitril/Valsartan在末期脏疾病 (ESRD) 患者的疗效和安全性.
- 确定该药物在透析患者的风险概况和潜在益处,特别是那些有抗性高血压或左心室功能障碍的人.
主要方法:
- 对ESRD患者中Sacubitril/Valsartan进行的观察性研究的综述.
- 在这个人群中分析生物幽默和心声学标志物.
主要成果:
- 目前的证据仅限于观察性研究,表明对生物道标记物和心脏功能有潜在的益处.
- 萨库比特里尔/瓦尔萨坦在ESRD患者中的应用仍然存在争议,原因是潜在的风险,如低血压和高胆血症.
结论:
- 在ESRD患者中Sacubitril/Valsartan的疗效和安全性需要通过长期随机对照试验进一步调查.
- 目前正在进行的试验至关重要,以澄清接受置换治疗的患者的益处和不良影响.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Renal Drug Clearance: Overview
255
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
255
Renal Drug Excretion: Overview
189
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
189
Hemodialysis III: Nursing Management
50
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
50
Heart Failure Drugs: Diuretics
425
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
425


